2020 No. 189
The Controlled Drugs (Supervision of Management and Use) (Amendment) Regulations 2020
Made
Laid before Parliament
Coming into force in accordance with regulation 1(2)
The Secretary of State in exercise of the powers conferred by sections 17(1) and (3)(b), 18 and 79(3) of the Health Act 20061 makes the following Regulations.
The Scottish Ministers have been consulted in accordance with section 24(6) of that Act.
Citation and commencement1
1
These Regulations may be cited as the Controlled Drugs (Supervision of Management and Use) (Amendment) Regulations 2020.
2
These Regulations come into force as follows—
a
regulations 1 to 3 come into force on 30th March 2020; and
b
regulations 4 to 7 come into force on 1st April 2020.
Amendment of the Controlled Drugs (Supervision of Management and Use) Regulations 20132
The Controlled Drugs (Supervision of Management and Use) Regulations 20132 are amended as follows.
Amendment of regulation 13
In regulation 1 (citation, commencement, application and expiry), omit paragraph (3), and in its heading, for “, application and expiry” substitute “and application”.
Insertion of regulation 1A4
After regulation 1 (citation, commencement and application), insert—
Review1A
1
The Secretary of State must from time to time—
a
carry out a review of the regulatory provision contained in these Regulations; and
b
publish a report setting out the conclusions of the review.
2
The first report must be published before 30th March 2025.
3
Subsequent reports must be published at intervals not exceeding 5 years.
4
Section 30(4) of the Small Business, Enterprise and Employment Act 20153 requires that a report published under this regulation must, in particular—
a
set out the objectives intended to be achieved by the regulatory provision referred to in paragraph (1)(a);
b
assess the extent to which those objectives are achieved;
c
assess whether those objectives remain appropriate; and
d
if those objectives remain appropriate, assess the extent to which they could be achieved in another way which involves less onerous regulatory provision.
5
In this regulation, “regulatory provision” has the same meaning as in sections 28 to 32 of the Small Business, Enterprise and Employment Act 2015 (see section 32 of that Act).
Amendment of regulation 25
In regulation 2(1) (interpretation)—
a
omit the definition of “NHS Protect”;
b
in the definition of “regular force”, omit from “(that is” to the end of that definition; and
c
for the definition of “reserve force”, substitute—
“reserve force” means the Royal Fleet Reserve, the Royal Naval Reserve, the Royal Marines Reserve, the Regular Reserve, the Army Reserve, the Air Force Reserve or the Royal Auxiliary Air Force;
Amendment of regulation 66
In regulation 6 (meaning of “responsible bodies”)—
a
in paragraph (b)—
i
omit sub-paragraph (iii), and
ii
in sub-paragraph (iv), omit “the Prescription Pricing Division of”; and
b
in paragraph (c), for sub-paragraph (iii), substitute—
iii
Public Health Scotland4,
Amendment of regulation 137
In regulation 13 (monitoring, assessing, investigating and taking action in relation to relevant individuals)—
a
in paragraph (3)—
i
in sub-paragraph (a), for “ePACT” substitute “ePACT2”, and
ii
in sub-paragraph (b), for “the Common Services Agency,” substitute “Public Health Scotland5,”;
b
in paragraph (6), omit sub-paragraph (c); and
c
in paragraph (7), in sub-paragraph (b)—
i
in paragraph (iii), omit sub-paragraph (cc), and
ii
in paragraph (iv), omit sub-paragraph (dd).
Signed by the authority of the Secretary of State for Health and Social Care.
(This note is not part of the Regulations)